BioCentury

2:35 AM GMT, Jan 19, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

GSK passes on Exelixis' XL784

Exelixis (NASDAQ:EXEL) said GlaxoSmithKline (LSE:GSK; NYSE:GSK) decided not to exercise its option to license

Read the full 146 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.